Scott Bizily's Stock Transactions in 4D Molecular Therapeutics

Scott Bizily, Chief Legal Officer of 4D Molecular Therapeutics, Inc., engaged in several stock transactions on October 24, 2025. He acquired 1,084 shares of common stock at $6.49 per share and disposed of 2,678 shares at $12.00 per share. Additionally, he disposed of 1,084 stock options (right to buy) with an exercise price of $6.49 per share. These transactions were made pursuant to a 10b5-1 trading plan adopted on June 6, 2025. The stock options are subject to a vesting schedule, with 1/48th of the shares vesting monthly starting from June 16, 2022, and fully vesting on the fourth anniversary of the vesting commencement date.